Business Context and Reporting Period
This Form 8-K Current Report was filed by Natera, Inc. on November 23, 2020, covering events occurring on November 17, 2020. The filing addresses corporate governance changes, specifically the expansion of the Board of Directors and the appointment of a new independent director.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is strictly focused on corporate governance and personnel appointments.
Material Changes
- Board Expansion: The Board of Directors increased its size from 10 to 11 members.
- New Appointment: Monica Bertagnolli, M.D., was appointed as a Class II director, effective November 17, 2020.
- Independence: Dr. Bertagnolli was determined to qualify as an independent director under the Securities Act of 1933 and Nasdaq listing standards.
- Term: Her initial term expires at the 2023 annual meeting of stockholders.
Guidance, Outlook, and Management Commentary
Compensation: Dr. Bertagnolli is eligible for the non-employee director compensation program but has elected not to receive cash or equity compensation for services rendered prior to the 2021 Annual Meeting of Stockholders.
Legal Protections: The Company entered into an Indemnification Agreement with Dr. Bertagnolli, providing for indemnification and advancement of litigation expenses to the fullest extent permitted by law.
Committee Assignments: No Board committee appointments were made for Dr. Bertagnolli at the time of this filing.
Risks and Contingencies: The filing states there are no family relationships between Dr. Bertagnolli and existing directors or officers, and she holds no direct or indirect material interest in transactions requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the press release issued on November 19, 2020 (Exhibit 99.1) for additional context on the appointment.
- Review the Indemnification Agreement (Exhibit 10.1) to understand the scope of legal protections provided to the new director.
- Confirm the updated Board composition and Class II director term expiration date (2023) in future proxy statements.
- Note that no financial performance data is available in this specific filing; refer to the most recent 10-Q or 10-K for financial metrics.